Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline.

Journal Article

Full Text

Duke Authors

Cited Authors

  • O'Shea, JC; Lorenz, TJ; Joseph, D; Kitt, MM; Greenberg, S; Lui, H; Cantor, W; Cohen, E; Tcheng, JE

Published Date

  • October 16, 2000

Published In

Volume / Issue

  • 86 / 8A

Start / End Page

  • 13I - 14I

International Standard Serial Number (ISSN)

  • 0002-9149